• Neurotensin: Analytical Design for NTR1 Studies

  2026-08-18

  Neurotensin is a versatile Neurotensin receptor 1 activator for connecting GPCR trafficking with miR-133α modulation. This guide adds an analytical-quality framework, showing how spectral interference controls can improve interpretation of gastrointestinal cell assays.

• KG-501: From CREB–KIX Mechanism to Translation

  2026-08-18

  KG-501 is a mechanism-focused probe for testing CREB–CBP KIX disruption in transcriptional, cancer, and macrophage models. This article places the compound within a translational framework, using colorectal cancer immunology findings to define appropriate evidence standards, assay strategies, and limitations.

• B7H3×CD3 BiTE mRNA-LNPs in Cancer Therapy

  2026-08-17

  Huang and colleagues developed an ionizable lipid nanoparticle system for delivering mRNA encoding a B7H3×CD3 bispecific T-cell engager. Their findings show that a single intravenous administration produced sustained BiTE expression and durable antitumor activity in models of hematologic malignancy and melanoma, addressing major limitations of recombinant BiTE therapy.

• PBS Liposomes for Macrophage Control Studies

  2026-08-17

  PBS Liposomes provide a phagocytosis-matched negative control that separates liposome handling effects from clodronate-mediated macrophage depletion. This workflow shows how to pair them with depletion, uptake, cytokine, and TRPM3-related assays for more defensible causal conclusions.

• Beyond Viability: Measuring Drug Responses in Cancer

  2026-08-16

  Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent components of anticancer drug response. This framework supports more interpretable in vitro screening by aligning endpoint selection and sampling time with the biological process being measured.

• Caffeine N2379: Reproducible Cell Assays

  2026-08-15

  This scenario-based guide explains how Caffeine (SKU N2379) can support better-controlled viability, proliferation, and cytotoxicity experiments. It covers assay interpretation, solvent compatibility, concentration planning, combination studies, and evidence-based vendor selection.

• CBD, FAAH, and Orofacial Inflammatory Pain

  2026-08-14

  A 2026 Brain Research Bulletin study shows that cannabidiol reduces both nociceptive and pain-related affective abnormalities in mouse inflammatory pain models through coordinated peripheral and central endocannabinoid mechanisms. Its design links FAAH, anandamide, inflammatory mediators, trigeminal activity, and amygdala serotonin dynamics, providing a framework for interpreting multidimensional analgesic responses.

• CBD Attenuates Orofacial Pain and Affective Deficits

  2026-08-14

  This 2026 study shows that cannabidiol (CBD) acts across peripheral inflammatory pathways, central pain circuits, and affective networks in mouse models. Its combination of behavioral, biochemical, receptor-related, and fiber-photometry analyses provides a mechanistic framework for treating both orofacial pain and associated emotional and cognitive disturbances.

• Extracellular Vesicle Release Inhibitors in TNBC

  2026-08-13

  McNamee et al. systematically compared four pharmacological strategies and their combinations for suppressing extracellular vesicle release from triple-negative breast cancer models. The study shows that heterogeneous EV populations collectively contribute to aggressive trait transfer and that substantial, but incomplete, release inhibition produces only a partial reduction in recipient-cell effects.

• Medroxyprogesterone Acetate: Applied Lab Workflows

  2026-08-13

  Medroxyprogesterone acetate enables controlled studies of progestin signaling across renal, reproductive, and neurobiology models. This workflow-focused guide covers dose design, solvent handling, receptor-aware controls, and troubleshooting for more reproducible MPA experiments.

• Oseltamivir acid Research Workflows

  2026-08-12

  Oseltamivir acid is an active influenza neuraminidase inhibitor for pairing enzyme assays, cell-based influenza virus replication inhibition, resistance studies, and exploratory oncology experiments. This practical guide connects formulation, assay design, combination testing, and translational model selection while separating product-backed findings from workflow starting points.

• Radioiodinated Balsalazide for Ulcerative Colitis Imaging

  2026-08-12

  The reference study developed and evaluated radioiodinated balsalazide as a colon-directed tracer for ulcerative colitis in mice. Its optimized labeling chemistry, 24-hour stability profile, and strong uptake in inflamed colon provide a practical framework for preclinical disease imaging while also highlighting important translational limitations.

• Milk-Derived EV Uptake in Intestinal Stem Cell Models

  2026-08-11

  The reference study establishes a polarity-aware porcine intestinal stem cell platform to examine milk-derived extracellular vesicle uptake in models that better reproduce epithelial organization than conventional cell lines. Its findings link apical accessibility, intestinal region, stemness-related responses, and pharmacological sensitivity to endocytosis, providing a useful framework for studying extracellular vesicle biology in intestinal tissues.

• ML365 Workflows for TASK1 Ion Channel Research

  2026-08-11

  ML365 combines nanomolar TASK1 inhibition with orthogonal assay compatibility, making it useful for ion-channel target validation and mechanistic neuroinflammation studies. This guide translates the aged-mouse postoperative cognitive impairment findings into practical workflows, controls, and troubleshooting strategies.

• ZK53 Human Mitochondrial Serine Protease ClpP Activator

  2026-08-10

  ZK53 is a selective human mitochondrial serine protease ClpP activator for connecting mitochondrial proteostasis failure with tumor-cell arrest and ferroptosis sensitivity. Its bacterial ClpP selectivity, orthogonal enzyme readouts, and established lung and colorectal cancer workflows make it useful for mechanism-focused research.

16426 records 1/1096 page Next 12345 下5页 Last page